CLINICAL CONSEQUENCES OF DEVELOPMENT OF RESISTANCE TO 3RD GENERATION CEPHALOSPORINS

被引:57
作者
FOLLATH, F [1 ]
COSTA, E [1 ]
THOMMEN, A [1 ]
FREI, R [1 ]
BURDESKA, A [1 ]
MEYER, J [1 ]
机构
[1] UNIV BASEL,BIOZENTRUM,DEPT MICROBIOL,CH-4051 BASEL,SWITZERLAND
关键词
D O I
10.1007/BF02013108
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:446 / 450
页数:5
相关论文
共 18 条
[1]   CEFOPERAZONE IN THE TREATMENT OF SEVERE OR COMPLICATED INFECTIONS [J].
BAILEY, RR ;
PEDDIE, B ;
BLAKE, E ;
BISHOP, V ;
REDDY, J .
DRUGS, 1981, 22 :76-86
[2]   TREATMENT OF SYSTEMIC PSEUDOMONAS-AERUGINOSA INFECTIONS WITH CEFTAZIDIME - CAUSES OF THERAPEUTIC FAILURE [J].
BLASER, J ;
BAUERNFEIND, A ;
VOGT, M ;
LUTHY, R .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1983, 108 (35) :1312-1317
[3]   GENTAMICIN VS CEFOTAXIME FOR THERAPY OF NEONATAL SEPSIS - RELATIONSHIP TO DRUG-RESISTANCE [J].
BRYAN, CS ;
JOHN, JF ;
PAI, MS ;
AUSTIN, TL .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1985, 139 (11) :1086-1089
[4]   RESISTANCE CAUSED BY DECREASED PENETRATION OF BETA-LACTAM ANTIBIOTICS INTO ENTEROBACTER-CLOACAE [J].
BUSH, K ;
TANAKA, SK ;
BONNER, DP ;
SYKES, RB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (04) :555-560
[5]   PROPHYLACTIC PARENTERAL CEPHALOSPORINS IN SURGERY - ARE THE NEWER AGENTS BETTER [J].
DIPIRO, JT ;
BOWDEN, TA ;
HOOKS, VH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (23) :3277-3279
[6]   CEFTAZIDIME IN SEVERE INFECTIONS - A SWISS MULTICENTER STUDY [J].
FRANCIOLI, P ;
CLEMENT, M ;
GEROULANOS, S ;
VONGRAEVENITZ, A ;
LUTHY, R ;
REGAMEY, C ;
STALDER, H ;
VOGT, M ;
WALDVOGEL, FA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 :139-146
[7]   USE OF CEFOTAXIME, A BETA-LACTAMASE STABLE CEPHALOSPORIN, IN THE THERAPY OF SERIOUS INFECTIONS, INCLUDING THOSE DUE TO MULTIRESISTANT ORGANISMS [J].
FRANCKE, EL ;
NEU, HC .
AMERICAN JOURNAL OF MEDICINE, 1981, 71 (03) :435-442
[8]   INFLUENCE OF 3RD-GENERATION CEPHALOSPORINS ON AEROBIC INTESTINAL FLORA [J].
GUGGENBICHLER, JP ;
KOFLER, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 :67-70
[9]  
KUNIN CM, 1981, REV INFECT DIS, V3, P745
[10]   CLINICAL-EVALUATION OF MOXALACTAM [J].
MATHISEN, GE ;
MEYER, RD ;
THOMPSON, JM ;
FINEGOLD, SM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (05) :780-786